Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Concetta Fargnoli

Showing results (241-250 of 284) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 14, 2023
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023Alexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.
BMC Medical Research Methodology|August 7, 2012
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studiesSara Raimondi, Sara Gandini, Maria Concetta Fargnoli, et al.
Plos One|August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasisEmanuele Scala, Matteo Megna, Paolo Amerio, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023Alexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
The Journal of Dermatological Treatment|February 6, 2026
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyClaudio Bonifati, Giuseppe Argenziano, Serena Lembo, et al.
Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026Alexander J Stratigos, Clio Dessinioti, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026Alexander J Stratigos, Clio Dessinioti, Claus Garbe, et al.
Dermatology Practical & Conceptual|April 14, 2025
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the "Save Your Skin" Screening CampaignPaola Savoia, Laura Cristina Gironi, Chiara Airoldi, et al.
Pageof 29

Showing results (241-250 of 284) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|September 14, 2023
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023Alexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
BMC Health Services Research|September 7, 2021
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal studyEmanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, et al.
BMC Medical Research Methodology|August 7, 2012
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studiesSara Raimondi, Sara Gandini, Maria Concetta Fargnoli, et al.
Plos One|August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasisEmanuele Scala, Matteo Megna, Paolo Amerio, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023Alexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
The Journal of Dermatological Treatment|February 6, 2026
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyClaudio Bonifati, Giuseppe Argenziano, Serena Lembo, et al.
Dermatologic Therapy|October 22, 2021
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) studyDelia Colombo, Luca Bianchi, Gabriella Fabbrocini, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026Alexander J Stratigos, Clio Dessinioti, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026Alexander J Stratigos, Clio Dessinioti, Claus Garbe, et al.
Dermatology Practical & Conceptual|April 14, 2025
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the "Save Your Skin" Screening CampaignPaola Savoia, Laura Cristina Gironi, Chiara Airoldi, et al.
Pageof 29